A Single Centre, Prospective, Open labeled Study to Evaluate Safety & Efficacy of NHPL/OZ-01 an Ayurvedic Formulation in patients with Musculoskeletal Pains

uZen Herbal Private Limited0 个研究点目标入组 200 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Subjects of either sex
•2.Age above 18 years
•3.Willing to give written consent
•4.Subjects suffering from Musculoskeletal pains: Myalgia, Neck pain, limb pain, low back pains, Joint Pains, Stiffness and Wide spread musculoskeletal pains.
•5.Pain score of at least 4 cm on a 10-cm linear visual analogue scale

•1Contraindications or Hypersensitivity to the active substances or to any of the excipients of the drug.
•2Subjects currently on any other NSAID therapy.
•3History or presence of any medical condition or disease according to the discretion of the Investigator.
•4History of significant renal or hepatic problems / abnormal functions.
•5History of significant asthma, urticaria or other allergic reactions
•6History of significant gastric and/or duodenal ulceration such as Mal-absorption syndrome.
•7History of diabetes, coronary artery disease and hypertension with or without complication
•8History of any chronic physical, hormonal, immune or psychiatric illness
•9Currently taking any herbal preparations
•10Individuals refusing to use appropriate non-hormonal birth control measures.
•11Subjects participating in any other trial.
•12Female subjects found positive in urine pregnancy test.
•13Lactating Mothers
•14Subjects not willing to comply with protocol requirements

发起方

uZen Herbal Private Limited